Upload
others
View
8
Download
0
Embed Size (px)
Citation preview
04.03.2014
1
Pharmaceutical Bio-Engineering
Dortmund, 04.03.2014
Laboratory of Chemical Biotechnology
Natural Product Biotechnology
Mattijs Julsing
Laboratory of Chemical Biotechnology
Construct, develop, and understand whole microbial cells as productive biocatalysts
Single step/multi step biocatalaysis , pathway engineering, cellular metabolism, process setup
Laboratory of Chemical Biotechnology(Prof. Andreas Schmid)
04.03.2014
2
Outline
Introduction natural products and their relevance in pharmacy
Introduction in some basic biotechnological concepts
Natural product biotechnology
applying the concepts for terpenoid synthesis / production
examples:artemisininlimonene and perillyl alcohol
How to develop a productive process for the biotechnological production of natural products?
Natural Products
natural product:
a chemical substance produced by a living organism:
a term commonly used for small molecules
a term commonly used in reference to chemical substances found in nature that have distinctive pharmacological effects.
such a substance is considered a natural product even if it can be prepared by total synthesis. (natural product synthesis is an important field in organic chemistry)
04.03.2014
3
Nature as source for medicines
Throughout history nature has inspired humans and served as a source formedicines
In our society, the relation between medicines and natural products is oftennot visible.
The use of natural products ≠ alternative medicine or homeopathy
…. but do realize
A large fraction of the world population still depends on medicines directly derived from natural sources
In many cultures traditional health care is accepted next to modern health care
Where can we (in western health care) find natural products… even today?
04.03.2014
4
Papaver somniverum
morfineHO
HO
N
O
H H
codeineHO
N
O
H H
O
Cinchona officinalis (bark)
N
N
CH3OHO H
H
kininequinine
04.03.2014
5
Cannabis sativa
OH
O
tetrahydrocannabinol (THC)
Natural products in pharmacy
In our society, the relation between medicines and natural products isoften not visible.
Why?
Major developments in organic synthesis during 20st century:chemical industry, natural product synthesis
organic synthesis replaced isolation from natural sources: aspirin
organic synthesis was used to make new semi-synthetic compounds
screening programs to find fully synthetic lead compounds
04.03.2014
6
Salix alba (white willow) chemical synthesis
OH
O
OH
OH
O
O
O
salicylic acid acetylsalicylic acid
Chemical analogues…. semi-synthetics
Morfine heroine
Penicillin numerous antibiotics
Quinine mefloquine, chloroquine
04.03.2014
7
New drugs (1981-2006)
Newman and Cragg, J Nat Prod (2007) 70, 461-477
N: natural productND: derived from natural product (semi-synthetic)S: synthetic S*: synthetic, but natural pharmacophoreNM: natural product mimic
What is with more complex and chiral structures?
Plant (natural source): limited access (low content, slow growth, ...)
Organic synthesis often possible, but time-consuming, side-products, expensive, production needs harsh chemicals, etc.
O
O
O
O
O
H3C
CH3
CH3
H H
H
H3CO OCH3
OCH3
O
O
OH
O
O
OO
OH
OOH
O O
O
O
O
OOH
NH
O
ONH
N
N
N
OH
R2H3CO
R1
OCOCH3OHH3COOC
04.03.2014
8
Biotechnology…. the use of enzymes.
Enzymes can be a good alternative (biotechnological approaches)
The use enzymes for chemical synthesis is called biocatalysis
Enzymes typically catalyze the conversion of specific substrates
highly substrate specific
highly regioselective
highly enantioselective
applied under mild reaction conditions
A need for chemical industries for more environmental friendly production processes:
green chemistry: process designthe use of sustainable substrates‚eco‘-efficiency
Biocatalytic processes: a continuum
Schrewe et al., 2013, Chem Soc Rev
04.03.2014
9
Isolated enzymes (cell-free systems)
indole oxidation to 2-oxoindole by chloroperoxidase (4.6 g L-1 ; 1h)
Van de Velde et al., 2000, B&B
• stable enzymes• cheap to buy (comercially
available) However, what to do when enzymes :
• have low stability in isolated form• are multicomponent • membrane-bound• are part of multi-step
pathways
Biocatalysis: Free enzymes or whole cells
e.g. lipases
• stable enzymes• easy to produce and
isolate• cheap to buy (comercially
available)
• cells produce the enzyme• enzymes with low stability
in isolated form• multicomponent enzymes• membrane-bound
enzymes• multi-step (or pathways)• cheap substrates
04.03.2014
10
Biocatalytic processes: a continuum
Schrewe et al., 2013, Chem Soc Rev
Advantages Disadvantages
Self-generating: catalyst synthesis and maintenance
Side product formation (overoxidation)
Higher stabilityNo purification required
Product degradationTransport limitations
Co-factor regeneration Product toxicity
Co-expression of redox partners(oxidoreductases)
Whole-cell biocatalysis
04.03.2014
11
Cofactor regeneration from host cell
hydroxylation of limonene into perillyl alcohol
recombinant E. coli containing CYP153A6
multicomponent enzyme
NADH-dependent: metabolic active cells
O2
OH
NADH H2O NAD+
CYP153A6
Cornelissen et al., 2011, J Ind Microb Biotech
Biotransformation directly linked to metabolism
proline hydroxylation
recombinant E. coli containing proline 4-hydroxylase
2-oxoglutatare as co-substrate directly derived from TCA cylcus
Shibasakic et al., 2000, Biosci Biotech Biochem
04.03.2014
12
Biocatalytic processes: a continuum
Schrewe et al., 2013, Chem Soc Rev
Fermentative processes
synthesis from cheap carbon sources (e.g. glucose)
multi-step
(artificial) biosynthetic pathways
Shibasaki et al., 2000, J Biosci BioengSzczebara et al., 2003, Nat BiotechRo et al., 2006, Nature
04.03.2014
13
Whole-cell biocatalysis
enzyme
Inhibitions Redox cofactors
Oxygen availability
Substrate uptake
Process setup
Enzyme kineticsSide reactions
Product excretion
Expression
Reaction equilibria
Toxicities
Intermediates
Overoxidation
Whole-cell biocatalysis (II)
enzyme
04.03.2014
14
Towards a productive process...
Enzyme Engineering
Cell Engineering
Reaction Engineering
http://opm.phar.umich.edu http://www.microfiltindia.com/
Process Engineering
Natural Product Biotechnology
terpenoid bioconversion/production as a well-investigated example
• diverse class of natural products built from isoprene units
• found in (almost) all living species
• >30,000 structures known
• pharmacologically relevant as anticancer, antimalarial and antimicrobialdrugs
• ingredients of plant essential oils, flavours , odors
04.03.2014
15
Terpene biosynthesis
Ajikumar et al., 2008, Mol. Pharmaceutics
C10
C15
C20
…. + C30, C40,…
C5 + C5
Artemisinin
sesquiterpene lactone
antimalarial compound
Artemisia annua (Chinese plant: quinhao)
the content of artemisinin in the leaves is influenced by many genetic, agricultural and environmental factors (Harvesting season, drying procedures and storage conditions)
total recovery of artemisinin can vary from 0.01 to 1.4% weight% of dry leaf mass
production in S. cerevisiae/E. coli possible?
Delabays et al., 2001, Curr Med Chem Ferreira et al., 2005, Plant Gen Res
04.03.2014
16
Terpene biosynthesis (II)
C10
C15
C20
…. + C30, C40,…
C5 + C5
synthesized in yeast
Ajikumar et al., 2008, Mol. Pharmaceutics
Artemisinin (II): metabolic engineering (cell eng.)
sesquiterpene lactone
antimalarial compound
Artemisia annua (Chinese plant: quinhao)
production in S. cerevisiae
Keasling, 2012, Metabolic Engineering
04.03.2014
17
Artemisinin (III)
recombinant S. cerevisiae
Keasling, 2012, Metabolic EngineeringNewman et al., 2006 B&BRo et al., 2006, Nature
amorphadiene: 27 g L-1
artemisinic acid: 2.5 g L-1
Productive process!!! (not yet artemisinin)
shorter process time compared to plant!!
artemisinic acid: bioprocess
artemisinin: photooxidation
2014: 60 tonnes (33% of market)
400 $ per kg
Nachrichten aus der Chemie, Februar 2014Nature, Vol. 494, February 2013
Artemisinin: the Sanofi-process
04.03.2014
18
Towards a productive process...
Enzyme Engineering
Cell Engineering
Reaction Engineering
http://opm.phar.umich.edu http://www.microfiltindia.com/
Process Engineering
Perillyl alcohol
in phase II clinical trials as an anti-tumor drug
oxygenated monoterpenoid (C10)
expensive compound
precursor limonene is cheap
OH
perillyl alcohol
O2
OH
NADH H2O NAD+
CYP153A6
limonene
Limonene: oil destillation from orange peals
04.03.2014
19
whole-cell biocatalyst
cytoplasmatic alkane monooxygenase
three component enzyme
originates from Mycobacterium sp. strain HXN-1500
NADH-dependent: regeneration by bacterial strain
living cells were applied
Biotransformation:
- Pseudomonas putida KT2440
growing on either citrate or glycerol
Figures adapted from: van Beilen and Funhoff, 2005, Curr. Opin. Biotechnol
OH
O2H2O
CYP153A6
Ferredoxin Ferredoxin reductase
2e-
.
NAD+
NADH + H+
2e-
.
Bacterial cytochrome P450 CYP153A6
Biotransformation with growing Pseudomonas cells:
a + b: (S)-limonene (□), (S)-perillyl alcohol (●), perillyl aldehyde (▲), perillic acid (♦), sum of terpenes (×), and biomass ()
c + d: productivity (○) and specific activity (●) profiles
citrate
glycerol
Selection of carbon- and energy source influences biocatalysis
but: side product formationCornelissen et al., 2011, J Ind Microb Biotech
04.03.2014
20
OHH H O OH O
7% 20%73%
Alcohol Aldehyde Acid
Side products are undesired
- Lower productivity
- Downstream processing
Pseudomonas dehydrogenases
Side product formation – overoxidation by Pseudomonas dehydrogenases
Cornelissen et al., 2011, J Ind Microb Biotech
Escherichia coli W3110
alcohol aldehyde
Change of bacterial host
E. coli: promising enzymatic background
no overoxidation by E. coli
OHH H O OH O
7% 20%73%
Alcohol Aldehyde Acid
Cornelissen et al., 2013, B&B
04.03.2014
21
E. coli W3110 (pCom8-PFR1500)
CYP153A6 in E. coli in a 2-LP setup
Cornelissen et al., 2013, B&B
Improving substrate uptake into E. coli
Hydrophobicity of the substrate
04.03.2014
22
The outer membrane of gram-negative bacteria constitutes an efficient barrier for hydrophobic molecules
known strategy: destabilizing the outer membrane by chemical treatment or permeabilization (unwanted: NADH needed)
Improving substrate uptake into E. coli
Modified from: van den Berg (2010) ChemBioChem, 11, 1339
Facilitated substrate uptake
AlkL:
• hypothetical role in substrate uptake
• direct evidence for alkane substrates
• eight-stranded -barrel protein
• proposed mechanism: bypassing the LPS layer by lateral diffusion of hydrophobic substrates into outer membrane
Model structure based on OmpW from E. coli
04.03.2014
23
outer membrane
periplasmic space
cytoplasmic membrane
AlkL
O2
OH
NADH H2O NAD+
CYP153A6
Facilitated substrate uptake (II)
E. coli W3110 (pCom8-PFR1500) and AlkL
Effect of AlkL on limonene biotransformation
AlkL improves limonene biotransformation
Improving the CYP153A6 would not make sense: substrate uptake limitation
Cornelissen et al., 2013, B&B
04.03.2014
24
Limonene Production E. coli
Can we produce limonene (and perillyl alcohol) in a fermentative process in E. coli?
Terpene biosynthesis (III)
C10
C15
C20
…. + C30, C40,…
C5 + C5
synthesized in yeastand E. coli
Ajikumar et al., 2008, Mol. Pharmaceutics
04.03.2014
25
Terpene biosynthesis (III)
Ajikumar et. al., Mol. Pharmaceutics ,2008
C10
C15
C20
…. + C30, C40,…
C5 + C5
synthesized in yeastand E. coli
Introducing 2 plant genes: enzymes active?
Enough C5-precursor in E. coli?
Is the volatility of limonene a problem?
Molecular Biology
P
atoB HMGS tHMGR
P
ERG12 ERG8 MVD1 idi pMBI
P
GPPS pET24a:AGPPS2
pBAD/TAC:LS
P
LS
pMevT
Sub-cloned into one single vector
+IPP
DMAPPAcetyl-CoA
Upstream Pathway Downstream Pathway
04.03.2014
26
Introduction of plant genes: active enzymes
in vitro assay: 0.5 g L-1 protein, 200 µM IPP/DMAPP
+IPP
DMAPP
Terpene biosynthesis (III)
Ajikumar et. al., Mol. Pharmaceutics ,2008
C10
C15
C20
…. + C30, C40,…
C5 + C5
synthesized in yeastand E. coli
Introducing 2 plant genes: enzymes active? YES
Enough C5-precursor in E. coli?
Is the volatility of limonene a problem?
04.03.2014
27
Molecular Biology
P
atoB HMGS tHMGR
P
ERG12 ERG8 MVD1 idi pMBI
P
GPPS pET24a:AGPPS2
pBAD/TAC:LS
P
LS
pMevT
Sub-cloned into one single vector
+IPP
DMAPPAcetyl-CoA
Upstream Pathway Downstream Pathway
Limonene Production E. coli
in vivo experimental setup (screw-capped baffeled shaking flasks)
• 40 ml M9* medium, 1 % (w/v) glucose, 24 h
Genetic and reaction engineering
04.03.2014
28
Terpene biosynthesis (III)
Ajikumar et. al., Mol. Pharmaceutics ,2008
C10
C15
C20
…. + C30, C40,…
C5 + C5
synthesized in yeastand E. coli
Introducing 2 plant genes: enzymes active? YES
Enough C5-precursor in E. coli? NO: YES (increased by genetic eng)
Is the volatity of limonene a problem? YES (reaction engineering)
Advantages:
limonene is volatile: circumvent evaporation
in situ product extraction in organic phase
controlled process
larger scale (in lab 2L, but …..)
decreasing product toxicity
application of high biomass concentrations possible
2-Liquid phase (2-LP) fermentation on reactor scale
04.03.2014
29
Limonene production
Up to 2.7 g L-1 produced in 42 h: productive process
Aim: Couple with CYP153A6 to produce perillyl alcohol value-added compound
Take home message
Natural products are still of interest for pharmacy
Nature products as source for new bioactive compounds
Derivatization of natural products delivers new drugs
Biotechnological process can be applied to:
produce natural products: e.g. as alternative source
convert natural products (biotransformation)
synthesize new non-natural natural products
by constructing artificial biosynthetic pathways
robust host organisms are a must
a biotechnological process is more than the introduction ofbiosynthetic genes